Engineering the third wave of biocatalysis

@article{Bornscheuer2012EngineeringTT,
  title={Engineering the third wave of biocatalysis},
  author={Uwe T. Bornscheuer and Gjalt Waling Huisman and Romas J. Kazlauskas and Stefan Lutz and Jeffrey C Moore and Karen T. Robins},
  journal={Nature},
  year={2012},
  volume={485},
  pages={185-194}
}
Over the past ten years, scientific and technological advances have established biocatalysis as a practical and environmentally friendly alternative to traditional metallo- and organocatalysis in chemical synthesis, both in the laboratory and on an industrial scale. Key advances in DNA sequencing and gene synthesis are at the base of tremendous progress in tailoring biocatalysts by protein engineering and design, and the ability to reorganize enzymes into new biosynthetic pathways. To highlight… Expand

Figures, Tables, and Topics from this paper

Future of Biocatalysis in the Synthesis of Organic Compounds
This chapter summarizes the future of biocatalysis, focusing particularly on the short- and long-term needs for growth in this field. The former category includes issues such as new types ofExpand
New generation of biocatalysts for organic synthesis.
TLDR
The advantages and applications of the most recent and attractive biocatalysts--reductases, transaminases, ammonia lyases, epoxide hydrolases, and dehalogenases--will be discussed herein and exemplified by the syntheses of interesting compounds. Expand
Recent advances in biocatalyst discovery, development and applications.
TLDR
This paper discusses new applications of selected biocatalysts including transaminases, cytochrome P450s, and Baeyer-Villiger monooxygenases, and highlights some of these recent advances with the focus on new approaches inBiocatalyst discovery and development. Expand
Recent trends in biocatalysis
TLDR
The research of biocatalysis is gradually moving towards the era of novel technology integration, intelligent manufacturing and enzymatic total synthesis. Expand
Biocatalysis for the synthesis of pharmaceuticals and pharmaceutical intermediates.
TLDR
This review discusses the recent discoveries, engineering, and applications of biocatalysts for the synthesis of pharmaceuticals and pharmaceutical intermediates. Expand
On the development of new biocatalytic processes for practical pharmaceutical synthesis.
TLDR
The recent developments in the field are discussed, including examples of processes leveraging hydrolases, reductases, transaminases, oxidases and other biocatalysts, focused on the preparation of important investigational and launched therapeutics. Expand
Biocatalysis: Enzymatic Synthesis for Industrial Applications
TLDR
A review of biocatalysis with a special focus on scalable chemical production using enzymes discusses the opportunities and limitations of enzymatic syntheses using distinct examples and provides an outlook on emerging enzyme classes. Expand
Improving and repurposing biocatalysts via directed evolution.
TLDR
The recent successes in the quest to enhance thermostability, stereoselectivity and activity of biocatalysts, as well as to create novel enzymes, over the last two years are discussed. Expand
Expanding the boundary of biocatalysis: design and optimization of in vitro tandem catalytic reactions for biochemical production
TLDR
This review will briefly summarize the strategies of designing and optimizing in vitro tandem catalytic reactions, highlight a few representative examples, and discuss the future trend in this field. Expand
Recent advances in biocatalyst development in the pharmaceutical industry
Biocatalysts are increasingly employed as more efficient and environmentally safer alternatives to traditional chemical catalysts in the manufacturing of fine chemicals. This is driven by advances inExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 107 REFERENCES
Dispelling the Myths--Biocatalysis in Industrial Synthesis
TLDR
Expect many new industrial applications of biocatalysis to be realized, from single-step enzymatic conversions to customized multistep microbial synthesis by means of metabolic pathway engineering. Expand
Advances in biocatalytic synthesis of pharmaceutical intermediates.
TLDR
This review aims to point at alternative reaction types and integrated multi-enzymatic steps that are emerging in large-scale applications. Expand
Combinatorial and computational challenges for biocatalyst design
  • F. Arnold
  • Environmental Science, Medicine
  • Nature
  • 2001
TLDR
The marriage of these approaches will allow us to generate the efficient, effective catalysts needed by the pharmaceutical, food and chemicals industries and should open up new opportunities for producing energy and chemicals from renewable resources. Expand
Development of a Practical Biocatalytic Process for (R)-2-Methylpentanol
(R)-2-Methylpentanol is an important chiral intermediate for the synthesis of certain medicinally important compounds, natural products, and liquid crystals. Here we describe the development of aExpand
Directed evolution drives the next generation of biocatalysts.
  • N. Turner
  • Biology, Medicine
  • Nature chemical biology
  • 2009
TLDR
Significant developments have occurred recently in enzyme function and properties, particularly with respect to library design, screening methodology, applications in synthetic transformations and strategies for the generation of new enzyme function. Expand
The Combination of Hydroformylation and Biocatalysis for the Large-Scale Synthesis of (S)-Allysine Ethylene Acetal
The compound, (S)-2-amino-5-[1,3]dioxolan-2-yl-pentanoic acid [(S)-allysine ethylene acetal], is a key intermediate in a number of angiotension-I converting enzyme (ACE) and neutral endopeptidaseExpand
Industrial methods for the production of optically active intermediates.
TLDR
For the industrial implementation of many transformations alternative methods are available and the advantages of the individual methods will be discussed herein and exemplified by syntheses of relevant compounds. Expand
Highly Enantioselective Reduction of a Small Heterocyclic Ketone: Biocatalytic Reduction of Tetrahydrothiophene-3-one to the Corresponding (R)-Alcohol
By leveraging enzyme evolution technologies, the enantioselectivity of a KetoREDuctase (KRED) towards the nearly spatially symmetrical ketone tetrahydrothiophene-3-one was increased from 63% ee toExpand
Biocatalytic Asymmetric Synthesis of Chiral Amines from Ketones Applied to Sitagliptin Manufacture
TLDR
An efficient biocatalytic process to replace a recently implemented rhodium-catalyzed asymmetric enamine hydrogenation for the large-scale manufacture of the antidiabetic compound sitagliptin is reported, underscoring the maturation of bioc atalysis to enable efficient, economical, and environmentally benign processes for the manufacture of pharmaceuticals. Expand
Development of a Biocatalytic Process as an Alternative to the (−)-DIP-Cl-Mediated Asymmetric Reduction of a Key Intermediate of Montelukast
A KetoREDuctase (KRED) engineered via directed evolution technologies catalyzed the asymmetric reduction of (E)-methyl 2-(3-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-oxopropyl)benzoate to theExpand
...
1
2
3
4
5
...